Back to search
Bilirubin-induced Neurologic Dysfunction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bilirubin-induced Neurologic Dysfunction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bilirubin-induced Neurologic Dysfunction trials you may qualify forThe aim of this study is to evaluate serum bilirubin/albumin (B/A) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neuro…
The aim of the research was to define the role of MRS and ABR as early predictors of bilirubin-induced neurologic dysfunction (BIND) in full-term neonates who r…
Most preterm newborns are managed by phototherapy to reverse hyperbilirubinemia with the intent to prevent bilirubin neurotoxicity. A threshold-based relationsh…
The aims of this observational bench project are to validate the performance of the miniaturized and modernized hematofluorometer that measures bilirubin capaci…
The investigators hypothesize that a new BIND (Bilirubin Induced Neurologic Dysfunction) scoring method adapted for the developing world (BIND II, developed by…